We are live on ! Find out more
FA

Forefront Analytics Portfolio holdings

AUM $110M
1-Year Est. Return 18.54%
This Fund
S&P 500
This Quarter Est. Return
+1%
1 Year Est. Return
+18.54%
3 Year Est. Return
+33.55%
5 Year Est. Return
+24.76%
10 Year Est. Return
AUM
$110M
AUM Growth
-$3.31M
Cap. Flow
-$4.24M
Cap. Flow %
-3.86%
Top 10 Hldgs %
87.21%
Holding
47
New
4
Increased
21
Reduced
14
Closed
8

Sector Composition

Rank Sector Weight
1 Healthcare 4.08%
2 Technology 2.26%
3 Financials 1.67%
4 Industrials 0.58%
5 Consumer Staples 0.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REGN icon
26
Regeneron Pharmaceuticals
REGN
$70.9B
$355K 0.32%
460
+33
+8% +$25.3K
TMO icon
27
Thermo Fisher Scientific
TMO
$198B
$285K 0.26%
579
-7
-1% -$3.8K
LEGN icon
28
Legend Biotech
LEGN
$4.31B
$283K 0.26%
+15,659
New +$299K
VTV icon
29
Vanguard Value ETF
VTV
$186B
$258K 0.24%
1,317
-2,148
-62% -$430K
DHR icon
30
Danaher
DHR
$144B
$244K 0.22%
1,288
+373
+41% +$79.4K
PM icon
31
Philip Morris
PM
$301B
$240K 0.22%
1,450
+13
+0.9% +$2.26K
DFSV
32
Dimensional US Small Cap Value ETF
DFSV
$8.11B
$222K 0.2%
+6,341
New +$224K
NKTX icon
33
Nkarta
NKTX
$186M
$92.5K 0.08%
43,835
+3,133
+8% +$7.01K
ZURA icon
34
Zura Bio
ZURA
$518M
$88.7K 0.08%
14,901
-4,676
-24% -$28.2K
GERN icon
35
Geron
GERN
$924M
$82.1K 0.07%
55,125
+3,805
+7% +$5.78K
ANNX icon
36
Annexon
ANNX
$950M
$78.9K 0.07%
14,240
+1,014
+8% +$5.71K
BCYC
37
Bicycle Therapeutics
BCYC
$294M
$66.8K 0.06%
14,394
+1,023
+8% +$5.85K
CTMX icon
38
CytomX Therapeutics
CTMX
$788M
$58.6K 0.05%
12,476
-6,223
-33% -$31.6K
MREO
39
Mereo BioPharma
MREO
$49.5M
$42.2K 0.04%
127,778
+96,010
+302% +$41.2K
AOK icon
40
iShares Core Conservative Allocation ETF
AOK
$806M
-58,682
Closed -$2.35M
EMLP icon
41
First Trust North American Energy Infrastructure Fund
EMLP
$4.12B
-18,435
Closed -$698K
HYG icon
42
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.9B
-3,290
Closed -$265K
IEI icon
43
iShares 3-7 Year Treasury Bond ETF
IEI
$18.2B
-4,740
Closed -$566K
IGF icon
44
iShares Global Infrastructure ETF
IGF
$10.9B
-3,968
Closed -$244K
LQD icon
45
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$35.2B
-2,021
Closed -$223K
MIRM icon
46
Mirum Pharmaceuticals
MIRM
$7.25B
-2,663
Closed -$210K
TIP icon
47
iShares TIPS Bond ETF
TIP
$14.5B
-2,228
Closed -$245K

Similar funds

Forefront Analytics's Q1 2026 Portfolio in Review

As of Q1 2026, Forefront Analytics held 47 positions worth $110M, down 2.9% from $113M the previous quarter. Its ten largest holdings account for 87% of the portfolio.

Forefront Analytics withdrew a net $4.24M in Q1 2026, closing 8 positions and reducing 14 holdings. Its most notable exit was iShares Core Conservative Allocation ETF, an estimated $2.35M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 4.1% of assets, up from 3.9% a quarter earlier, followed by Technology and Financials.

Against the trend, Forefront Analytics opened a new position in Schwab US Dividend Equity ETF worth $464K.

  • Forefront Analytics's largest Q1 2026 buy was Schwab US Dividend Equity ETF: 15,119 shares worth $464K.
  • Forefront Analytics added most to FlexShares STOXX Global ESG Select Index Fund in Q1 2026, an estimated $4.41M increase.
  • Forefront Analytics's biggest Q1 2026 reduction was iShares MSCI USA Momentum Factor ETF, cutting an estimated $6.64M.
  • Forefront Analytics fully exited iShares Core Conservative Allocation ETF in Q1 2026, selling an estimated $2.35M.
  • Forefront Analytics's ten largest holdings make up 87% of its $110M portfolio in Q1 2026.
  • Forefront Analytics opened 4 new positions and closed 8 in Q1 2026.
  • Forefront Analytics's portfolio value fell 2.9% quarter-over-quarter to $110M.

Based on Forefront Analytics's 13F filing for Q1 2026, filed 13 May 2026.